| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Helicases | 2 | 2022 | 101 | 1.510 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 182 | 1.510 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 425 | 1.320 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 876 | 1.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 2062 | 1.110 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 221 | 1.040 |
Why?
|
| Prostatic Neoplasms | 9 | 2022 | 5778 | 1.020 |
Why?
|
| Inflammation | 5 | 2022 | 2514 | 0.980 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 41 | 0.920 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 640 | 0.920 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 16 | 0.870 |
Why?
|
| Guanidines | 1 | 2022 | 60 | 0.860 |
Why?
|
| Keto Acids | 1 | 2022 | 59 | 0.850 |
Why?
|
| Prostate | 6 | 2014 | 1090 | 0.850 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 68 | 0.840 |
Why?
|
| Transaminases | 1 | 2022 | 76 | 0.840 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 121 | 0.780 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 170 | 0.760 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 559 | 0.720 |
Why?
|
| Stromal Cells | 5 | 2014 | 815 | 0.690 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1684 | 0.650 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 7 | 0.640 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 712 | 0.610 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 853 | 0.590 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 277 | 0.580 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 848 | 0.570 |
Why?
|
| Retroviridae | 1 | 2017 | 323 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 1109 | 0.540 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 225 | 0.520 |
Why?
|
| Neoplasms | 5 | 2023 | 15180 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 8882 | 0.410 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1215 | 0.410 |
Why?
|
| Mice | 17 | 2022 | 34393 | 0.410 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 3879 | 0.340 |
Why?
|
| Animals | 20 | 2022 | 59489 | 0.330 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 14561 | 0.330 |
Why?
|
| Androgens | 3 | 2023 | 514 | 0.320 |
Why?
|
| Mice, SCID | 2 | 2022 | 1865 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 222 | 0.290 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 107 | 0.250 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 986 | 0.240 |
Why?
|
| Signal Transduction | 5 | 2023 | 11972 | 0.240 |
Why?
|
| Proteins | 4 | 2014 | 1953 | 0.230 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 411 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2362 | 0.220 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 645 | 0.210 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 10 | 0.200 |
Why?
|
| Staphylococcus | 1 | 2001 | 86 | 0.200 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 283 | 0.180 |
Why?
|
| Kupffer Cells | 1 | 2020 | 41 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 836 | 0.180 |
Why?
|
| Th1 Cells | 1 | 2021 | 252 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5672 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 164 | 0.170 |
Why?
|
| Protein Conformation | 3 | 2003 | 1257 | 0.170 |
Why?
|
| Hepatitis | 1 | 2020 | 93 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 133 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 703 | 0.160 |
Why?
|
| Cell Line | 4 | 2021 | 5071 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 275 | 0.160 |
Why?
|
| Humans | 20 | 2023 | 262248 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 6927 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 980 | 0.150 |
Why?
|
| Ribosomes | 1 | 1997 | 147 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 15709 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1540 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 674 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1498 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 444 | 0.140 |
Why?
|
| Cell Survival | 1 | 2022 | 3042 | 0.130 |
Why?
|
| Calcium | 1 | 2022 | 1545 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 994 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 250 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 220 | 0.130 |
Why?
|
| Carcinoma | 1 | 2007 | 2582 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 1077 | 0.130 |
Why?
|
| Male | 14 | 2023 | 123338 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 1281 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 13 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 7218 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1541 | 0.130 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 5124 | 0.130 |
Why?
|
| Pteridines | 1 | 2014 | 34 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2014 | 293 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 84 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 669 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 421 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 729 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 89 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 5378 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 874 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2014 | 121 | 0.120 |
Why?
|
| DNA Repair | 1 | 2021 | 1870 | 0.110 |
Why?
|
| DNA Damage | 1 | 2021 | 1947 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 391 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 3818 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 216 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2014 | 4303 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 238 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4126 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 973 | 0.100 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1033 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 687 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1221 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 3 | 2007 | 1545 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 999 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 584 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1031 | 0.090 |
Why?
|
| Nitriles | 1 | 2014 | 904 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 812 | 0.080 |
Why?
|
| Disease Progression | 2 | 2013 | 6693 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1834 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2014 | 3529 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2015 | 1027 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 353 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3632 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 1313 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2021 | 3347 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 220 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 888 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2014 | 6129 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 43 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 2904 | 0.060 |
Why?
|
| Apoptosis | 2 | 2017 | 7601 | 0.060 |
Why?
|
| Female | 3 | 2022 | 142293 | 0.060 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 114 | 0.060 |
Why?
|
| Muramidase | 1 | 2003 | 108 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 24 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 649 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 1040 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1533 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2014 | 7241 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9195 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 229 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 209 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 337 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 2170 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 579 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2860 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 120 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1740 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 146 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 992 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 3189 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 18 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 1487 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 260 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 606 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 371 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 642 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 591 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 1208 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 882 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 3438 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 11571 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 72 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 191 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 148 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 358 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7545 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 626 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 377 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 2462 | 0.030 |
Why?
|
| Organoids | 1 | 2014 | 289 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 2915 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 663 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1001 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1997 | 1207 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 939 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 2467 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 4386 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 6255 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 3127 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 2089 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2215 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1395 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2891 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 12984 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 835 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 591 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 4886 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4043 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 128 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 310 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 375 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 109 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3233 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5155 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 528 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 173 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 702 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3550 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2028 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 267 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 329 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 634 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 1516 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 33028 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 5598 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4563 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7793 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6062 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21494 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 15167 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 78179 | 0.000 |
Why?
|